In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DermaTech Pty. Ltd.

Division of Bausch Health Companies Inc.
www.dermatech.com.au

Latest From DermaTech Pty. Ltd.

Valeant Includes OTCs In Bid For Dramatic Growth By 2013

The Ontario-based firm has its sights set on becoming a top-15 pharma company with a $50 billion market capitalization by the end of 2013. Emerging markets and consumer health products, including the recent iNova and Fleming deals, play a big part in Valeant’s plans.

BioPharmaceutical Consumer

Valeant Includes OTCs In Bid For Dramatic Growth By 2013

The Ontario-based firm has its sights set on becoming a top-15 pharma company with a $50 billion market capitalization by the end of 2013. Emerging markets and consumer health products, including the recent iNova and Fleming deals, play a big part in Valeant’s plans.

BioPharmaceutical Consumer

Valeant Includes OTCs In Bid For Dramatic Growth By 2013

The Ontario-based firm has its sights set on becoming a top-15 pharma company with a $50 billion market capitalization by the end of 2013. Emerging markets and consumer health products, including the recent iNova and Fleming deals, play a big part in Valeant’s plans.

BioPharmaceutical Consumer

Valeant Includes OTCs In Bid For Dramatic Growth By 2013

The Ontario-based firm has its sights set on becoming a top-15 pharma company with a $50 billion market capitalization by the end of 2013. Emerging markets and consumer health products, including the recent iNova and Fleming deals, play a big part in Valeant’s plans.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
      • Transdermal
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Bausch Health Companies Inc.
  • Senior Management
  • Maree Laughton, Fin. Mgr.
    Thomas Cheng, Dir., Scientific Aff.
  • Contact Info
  • DermaTech Pty. Ltd.
    Phone: (61) 02 8884 7000
    5 Celebration Dr.
    Unit 517
    Bella Vista, 2153
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register